Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11034765 Anti-PD-1 antibodies and compositions

Patent 11034765 was granted and assigned to Symphogen on June, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

110347650

Patent Inventor Names

Gunther Galler0

Mikkel Pedersen0

Monika Gad0

Thomas Bouquin0

Ivan D. Horak0

Klaus Koefoed0

Michael Kragh0

Date of Patent

June 15, 2021

Patent Application Number

157653370

Date Filed

September 30, 2016

Patent Citations Received

‌

US Patent 11359018 Anti-PD-1 antibodies and compositions

‌

US Patent 11939380 Combination therapies targeting PD-1, TIM-3, and LAG-3

Patent Primary Examiner

‌

Nelson B Moseley, II

Patent abstract

This invention relates to anti-PD-1 antibodies and methods of using them in treating diseases and conditions related to PD-1 activity, e.g., cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11034765 Anti-PD-1 antibodies and compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API